Re-Vana Therapeutics based in Northern Ireland and Tampa Florida, is a specialty ocular therapeutic and drug delivery company focused on the development of sustained release biologics and small molecules.

The Re-Vana platforms, which includes EyeLiefÒ and OcuLiefÒ photocrosslinked technologies, can deliver at least 6 months sustained delivery of large molecule biologics, including anti-VEGF therapies. Re-Vana’s technology could also spur a new generation of small molecule therapeutics enabling up to 12 months delivery or greater.


Visit sponsor site

Thanks to the generosity of our sponsors, registration for our 2021 virtual forums is complimentary for all delegates.

To view all of our sponsors, please click here